IBDEI1C6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22714,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,22714,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,22715,0)
 ;;=N13.6^^87^983^73
 ;;^UTILITY(U,$J,358.3,22715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22715,1,3,0)
 ;;=3^Pyonephrosis
 ;;^UTILITY(U,$J,358.3,22715,1,4,0)
 ;;=4^N13.6
 ;;^UTILITY(U,$J,358.3,22715,2)
 ;;=^101552
 ;;^UTILITY(U,$J,358.3,22716,0)
 ;;=N30.91^^87^983^19
 ;;^UTILITY(U,$J,358.3,22716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22716,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,22716,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,22716,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,22717,0)
 ;;=N30.90^^87^983^20
 ;;^UTILITY(U,$J,358.3,22717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22717,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,22717,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,22717,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,22718,0)
 ;;=N41.9^^87^983^38
 ;;^UTILITY(U,$J,358.3,22718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22718,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,22718,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,22718,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,22719,0)
 ;;=N70.91^^87^983^75
 ;;^UTILITY(U,$J,358.3,22719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22719,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,22719,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,22719,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,22720,0)
 ;;=N70.93^^87^983^74
 ;;^UTILITY(U,$J,358.3,22720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22720,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,22720,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,22720,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,22721,0)
 ;;=N70.92^^87^983^55
 ;;^UTILITY(U,$J,358.3,22721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22721,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,22721,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,22721,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,22722,0)
 ;;=N73.9^^87^983^37
 ;;^UTILITY(U,$J,358.3,22722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22722,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,22722,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,22722,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,22723,0)
 ;;=A56.11^^87^983^36
 ;;^UTILITY(U,$J,358.3,22723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22723,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,22723,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,22723,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,22724,0)
 ;;=N73.5^^87^983^64
 ;;^UTILITY(U,$J,358.3,22724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22724,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,22724,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,22724,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,22725,0)
 ;;=N72.^^87^983^35
 ;;^UTILITY(U,$J,358.3,22725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22725,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,22725,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,22725,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,22726,0)
 ;;=N76.3^^87^983^92
 ;;^UTILITY(U,$J,358.3,22726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22726,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,22726,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,22726,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,22727,0)
 ;;=N76.1^^87^983^88
 ;;^UTILITY(U,$J,358.3,22727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22727,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,22727,1,4,0)
 ;;=4^N76.1
